Cover Image

A case of Merkel cell carcinoma development under treatment with a Janus kinase inhibitor

Saved in:

Bibliographic Details
Main Authors:	Yuta Koike, MD, PhD (Author), Naoya Murayama, MD (Author), Yutaka Kuwatsuka, MD, PhD (Author), Atsushi Utani, MD, PhD (Author)
Format:	Book
Published:	Elsevier, 2017-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
by: David Nash, BHSc, et al.
Published: (2023)

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
by: Sang-Doo Lee, MD, et al.
Published: (2022)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020)

Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series
by: Jason M. Rizzo, MD, PhD, et al.
Published: (2021)

Merkel cell carcinoma associated with tofacitinib therapy
by: Luke S. Wallis, MD, et al.
Published: (2021)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020)

Perforated gastric metastasis of Merkel cell carcinoma: Case report and review of the literature
by: Darshan Trivedi, MD, PhD, et al.
Published: (2017)

Merkel cell carcinoma in the context of follicular lymphoma treated with radiation and avelumab
by: Aya Nishizawa, MD, PhD, et al.
Published: (2024)

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
by: Song Y. Park, MD, et al.
Published: (2021)

Disparities in Janus kinase inhibitor access for alopecia areata: a retrospective analysis
by: Elizabeth J. Klein, MD, et al.
Published: (2024)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)

Incidence and outcomes of Merkel cell carcinoma related to Merkel cell polyomavirus status in Iceland in 1981-2023Capsule Summary
by: Maria Vygovska, MD, et al.
Published: (2024)

Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies
by: Daniel Wenzel, MD, et al.
Published: (2024)

An Aggressive Presentation of Merkel Cell Carcinoma: A Case Report
by: Zemni Ines MD, et al.
Published: (2020)

Survival outcomes and epidemiology of Merkel cell carcinoma of the lower limb and hip: A Surveillance, Epidemiology, and End Results analysis 2000-2018Capsule Summary
by: Matteo Scampa, MS, et al.
Published: (2022)

Comorbid immunosuppression in Merkel cell carcinoma: A retrospective database study
by: Paul Riviere, MD, et al.
Published: (2022)

Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
by: John Yeakel, MD, et al.
Published: (2021)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020)

A case of aggressive squamous cell carcinoma with lymphovascular invasion during treatment with the Janus kinase inhibitor tofacitinib
by: Ahmad I. Aleisa, MD, et al.
Published: (2020)

Merkel cell carcinoma: Epidemiology, disease presentation, and current clinical practice outcomesCapsule Summary
by: Marita Yaghi, MD, et al.
Published: (2022)

Aromatase inhibitor for the treatment of primary mucinous carcinoma of the skin with distant metastasis
by: Hideaki Miyachi, MD, PhD, et al.
Published: (2018)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review
by: Mitra Rezaei, MD, et al.
Published: (2022)

Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023)

Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
by: Nicolas Caudrelier, MD, et al.
Published: (2023)

Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management
by: Alyssa Breneman, BA, et al.
Published: (2021)

Merkel Cell Carcinoma With Isolated Pancreatic Metastasis
by: Prasanth Lingamaneni MD, et al.
Published: (2021)

Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib
by: Jannett Nguyen, MD, et al.
Published: (2021)

Fluorodeoxyglucose-avid cosmetic poly-L-lactic acid filler on surveillance imaging for Merkel cell carcinoma
by: Emily Y. Kim, BS, et al.
Published: (2024)

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
by: Abrahim Abduelmula, BScN, et al.
Published: (2022)

A case of bilateral plantar pseudo-Kaposi sarcoma successfully treated with propranolol
by: Takaaki Mine, MD, et al.
Published: (2021)

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor
by: Alison H. Kucharik, MD, et al.
Published: (2024)

Microcystic adnexal carcinoma mimicking basal cell carcinomaKey message
by: Ximena Calderón-Castrat, MD, et al.
Published: (2017)

Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore
by: Yik Weng Yew, MBBS, MPH, PhD, et al.
Published: (2023)

Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012)

Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review
by: Siddhartha Sood, HBSc, et al.
Published: (2024)

Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient
by: Kelsey E. Hirotsu, MD, et al.
Published: (2021)

Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid
by: Chigusa Yamashita, MD, et al.
Published: (2022)

Mohs micrographic surgery reduces the need for a repeat surgery for primary Merkel cell carcinoma when compared to wide local excision: A retrospective cohort study of a commercial insurance claims database
by: Duy C. Tran, MD, et al.
Published: (2022)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
by: Fabienne Ballanger, et al.
Published: (2023)